Adding an investigational nonsteroidal mineralocorticoid receptor antagonist (MRA) to an SGLT2 inhibitor led to a superior ...

WASHINGTON (AP) -- The Food and Drug Administration on Wednesday approved a new diabetes drug from Bristol-Myers Squibb and AstraZeneca that uses a novel approach to reduce blood sugar. Farxiga is a ...

The Food and Drug Administration on Wednesday approved a new diabetes drug from Bristol-Myers Squibb and AstraZeneca that uses a novel approach to reduce blood sugar. Farxiga is a once-a-day tablet ...

Qtern should only be used in patients who tolerate dapagliflozin 10mg. AstraZeneca announced that the Food and Drug Administration (FDA) has approved Qtern (dapagliflozin and saxagliptin) tablets as ...

Drug firm Alembic Pharmaceuticals on July 23 said it has received tentative approval from the US health regulator for Dapagliflozin Tablets, a medication that helps to reduce blood glucose levels. The ...